Boston Scientific ($BSX) has launched a U.S. trial of two next-generation leads for defibrillators and pacemakers, working toward FDA approval after completing the first implant. The devices, Acuity X4 for pacers and Reliance 4-Front for ICDs, are quadripolar technologies, designed to maximize effectiveness by offering more flexible stimulation. Both are already CE marked and on the market overseas. More